Showing posts with label India. Show all posts
Showing posts with label India. Show all posts

Friday, June 28, 2013

China takes anti-dumping measures on Indian and Japanese pyridine import

On May 27, 2013, the Ministry of Commerce of P. R. China issued an announcement that China preliminarily judged that Indian and Japanese companies dumped pyridine to China, which damaged China's pyridine industry. The certain period of this pyridine dumping investigation was July 1, 2011-June 30, 2012, and the certain period of China's pyridine industry injury was Jan.1, 2008-June 30, 2012.
 
From now on Chinese companies import pyridine from those companies will be levied guarantee funds by China's customs based on their margin of dumping. In detail, as for Indian companies, the guarantee funds levy ratio of Jubilant Life Sciences Limited is 24.6%, while that of other Indian companies is 57.4%. As for Japanese companies, the guarantee funds levy ratio of all Japanese companies who exported pyridine to China is 47.9%, including Koei Chemical Co., Ltd., Daicel Corporation and Nippon Steel Chemical Co., Ltd., etc. (Guarantee funds=Import price*Guarantee funds levy ratio *{1+VAT rate of imported goods })

According to the Ministry of Commerce's announcement, this anti-dumping investigation on pyridine products in China was initiated by Chinese pyridine manufacturers. China's four major pyridine manufacturers, namely Anhui Guoxing Biochemical Co., Ltd., Nanjing Redsun Biochemical Co., Ltd., Weifang Luba Chemical Co., Ltd. and Nantong Reilly Chemical Co., Ltd., submitted the application for investigation formally on Aug. 2, 2012.
 
The four applicants indicated that Japanese and Indian companies dumped pyridine products in China during 2008–H1 2012 by ways of increasing quantity and decreasing price. Owing to the low-price dumping, as indicated by the four applicants, the total market share of pyridine products from Japan and India has floated around 20% in China these years, which oppressed Chinese pyridine industry severely, for example, causing price inhibition, oppression on gross profit margin, sluggish investment return, employment atrophy and so forth. 
 
Shown by the data from the Ministry of Commerce's announcement, China's pyridine capacity and output have kept increasing in recent years. The domestic sale volume and revenue are also experiencing an increase. However, oppressed by the low price of pyridine from Japan and India, domestic pyridine manufacturers had to lower their pyridine prices, which caused slipped gross profit these years. In detail, the domestic gross profit of pyridine was about USD4.74 million with a year-on-year decrease of 39% in 2011, although the sale revenue saw a year-on-year growth of 14%.
 
Fortunately, affected by the investigation, the domestic pyridine price has seen a continuous uptrend from Aug. 2012 to early June 2013. In detail, the ex-factory price of pyridine 99.9% kept increasing from USD4,145/t in Aug. 2012 to USD5,531/t in May 2013 without sharp fluctuations. On May 31, 2013, the delivery price of pyridine in Shanghai Port from Jubilant Life Sciences Limited was about USD6,520/t (RMB40,000/t), while it was about USD4,824/t (RMB30,000/t) in early Nov. 2012. It's predicted that with increasing profit, pyridine business also stimulates pyridine companies' financial performance in 2013.

The news above was sourced from Herbicides China News issued by CCM in June

Table of Contents of Herbicides China News 1306:
Nanjing Redsun and Hubei Sanonda see increase in stock price
Noposion's raising projects start to get profit
CAC Nantong completed 400t/a fluorochloridone and 400t/a asulam TC production lines
Anhui Futian plans for 600t/a mesotrione TC production line
Jiangsu CF to construct 2,4-D project
Lianyungang Langxuan aims at 2,4-D market
China's new pesticide enterprise, Yancheng Taihe, with USD17.67 million project
China takes anti-dumping measures on Indian and Japanese pyridine import
Pendimethalin sees mediocre development in China
Atrazine experienced intense supply in early June 2013
Export volume of picloram increased in 2012
Export business of isopropylamine facing slightly gloomy situation
17 new registrations of herbicide technical in China in May 2013
Price Review in June 2013

Herbicides China News, a monthly publication issued by CCM on 15th, provides you with the latest occurrences, exclusive analysis on the market trend as well as professional reviews on competitiveness of companies, products and relative industries in China’s herbicide industry.

CCM is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of more than 150 dedicated highly-educated professionals, CCM offers Market Data, Analysis, Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis, and consultancy service. 

For more information, please visit http://www.cnchemicals.com.

Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Mansion, No.80 Xianlie Zhong Road, Guangzhou 510070, China
Tel: 86-20-37616606
Email: econtact@cnchemicals.com


Tuesday, February 21, 2012

What Kinds of Investment Opportunities in BRICS?

BRICS (Brazil, Russia, India, China and South Africa) are the most promising countries in global economy. With the background of more cooperation with other countries, there must be enormous investment opportunities in these five countries. How to figure out the investment opportunities is the most concerned issue. CCM International, a leading consulting company with more than 10 years experiences in market research, will publish the report of “Investment Environment Analysis in BRICS” in 2012, showing you what kinds of potentials to make investment in BRICS.

Providing a comprehensive overview of the BRICS about its development and cooperation mechanism, the report will have in-depth analysis on investment environment of these five countries, including industrial advantages and disadvantages, political and legal environment, taxation and financing system, hotspot and problem in economy, as well as population characteristic and cost of labor force. By obtaining the detailed information of FDI (Foreign Direct Investment), investors can discover the potential investment opportunities in the BRICS from 2012 to 2020.

In the past decade, the growth rate of GDP in China, India, Russia and Brazil ranked top in the whole world, while South Africa is the largest economic body in Africa. The total GDP in these five countries accounted for 18% of the world in 2010. BRICS are playing a more important role in economy and policy around the world.

Actually, BRICS have complementary advantages: Brazil is the world’s raw material base, abundant in agriculture products and mineral resources; Russia is rich in petroleum and natural gas; India has the advantage of outsourcing services; China is strong in manufacturing and it is called the centre of world factory; South Africa, the most developed country in economy in Africa, has abundant mineral resources and solid industrial foundation. On April 14, 2011, the BRICS signed the Framework Agreement on Financial Cooperation within the BRICS Inter-Bank Cooperation Mechanism in Sanya, China, which will further promote the cooperation within the BRICS.

However, facing global warming, global economic crisis, competition from other emerging countries, BRICS have been confronted with great challenges, such as rising cost of labor force, environmental protection. How is the current situation of investment environment in the BRICS, and where are the investment opportunities in the BRICS in the following ten years? This report will give you the answers. If you are interested in this report, please do not hesitate to contact us at
econtact@cnchemicals.com or 86-20-37616606.


About CCM International
CCM International is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of more than 150 dedicated highly-educated professionals. CCM International offers Market Data, Analysis, Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis all through its new proprietary product ValoTracer. For more information, please visit http://www.cnchemicals.com.

CCM International Ltd.
Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Mansion, No.80 Xianlie Zhong Road, Guangzhou 510070, China
Tel: 86-20-37616606

Thursday, December 22, 2011

Survey of PAP and Paracetamol in Asia Pacific Comes Out

CCM International newly published “Survey of PAP and Paracetamol in Asia Pacific” in December 2011. The report provides you with detail information of production, IE and consumption situation of targeted Asia Pacific countries. By analyzing the strengths and weaknesses of different regional producers and their investment environment, this report reveals the challenge and opportunity in the AP paracetamol market. It is perfect for you to learn a comprehensive AP paracetamol market and make wiser business decisions.

Asia is the largest origin of paracetamol, as China and India supply 80% of the global paracetamol market in 2010. Meanwhile, the huge population makes it the largest consumption market of the world. Asia consumes 65,400 tonnes of paracetamol—half of the global output of 2010. As the economy develops, the Asia market will become more and more important.
 
In this report, the six most populous countries of AP including China, India, Indonesia, Bangladesh, Pakistan and Japan are well studied. Based on the potential of the current market, the panorama of Asian paracetamol can be drawn out.

What are the latest production situation in AP and the consumption details of PAP and paracetamol? What is the market change of PAP and paracetamol in 2006-2010? How is the future development of PAP and paracetamol in 2011-2015? All these aspects can be found in this report. In addition, relevant policies and regulations are also covered in this report. This report combines CCM International's expertise in PAP and paracetamol market research. If you are interested in this report, please do not hesitate to contact us at econtact@cnchemicals.com.

Key sections of this report:
- PAP production situation in China, 2008-2010
- Import and export situation of PAP in China, 2000-2010
- Detailed description on consumption patterns and various application fields, 2010
- Forecast on PAP supply and demand of in China, 2011-2015
- The paracetamol production details in AP, 2008-2010
- Import and export situation of paracetamol in AP, 2006-2010
- Paracetamol consumption pattern in AP, 2009-2010
- Forecast on paracetamol supply and demand of in China, 2011-2015


About CCM
CCM is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of more than 150 dedicated highly-educated professionals. CCM offers Market Data, Analysis, Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis all through its new proprietary product ValoTracer.
For more information, please visit http://www.cnchemicals.com.
CCM International Ltd.
Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Mansion, No.80 Xianlie Zhong Road, Guangzhou 510070, China
Tel: 86-20-37616606